Barbara Trautner, MD, PhD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Genentech
    Topic: 
    tocilizumab for COVID pneumonia
  • Attribution: 
    Self
    Type of financial relationship: 
    Research Funding (if you were the principal or named investigator)
    Ineligible company: 
    Genentech
    Topic: 
    EMPACTA trial (tocilizumab for COVID pneumonia)
Return to 2022 Infectious Disease Board Review Course